SSSilvana Salardi

Silvana Salardi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Silvana Salardi has a total of 90 co-authors. Here are the top co-authors by number of shared publications:

  • Giulio Maltoni

    Department of Pediatrics S. Orsola‐Malpighi Hospital, University of Bologna Bologna Italy

    7 shared publications
  • Stefano Zucchini

    Department of Pediatrics, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 11, 40138, Bologna, Italy

    5 shared publications
  • Vittoria Cauvin

    Pediatric Unit S. Chiara Hospital Trento Italy

    5 shared publications
  • Alessandro Cicognani

    Department of Pediatrics, S. Orsola‐Malpighi Hospital, University of Bologna, Bologna, Italy

    4 shared publications
  • Dario Iafusco

    Department of Pediatrics, Second University of Naples, Naples, Italy

    4 shared publications
  • Riccardo Schiaffini

    Endocrinology and Diabetes Palidoro Unit, University Department of Pediatric Medicine Bambino Gesù Children's Hospital, IRCCS Rome Italy

    4 shared publications

Latest Publications

  • Open Access

    Decreasing prevalence of retinopathy in childhood‐onset type 1 diabetes over the last decade: A comparison of two cohorts diagnosed 10 years apart

    by Silvana Salardi, Massimo Porta, Giulio Maltoni, Marta Bassi, Nicola Minuto, Giuseppe D'ANnunzio, Tamara Baltatescu, Maria Ariaudo, Stefano Zucchini, Gabriella Levantini, et al.

    Aim: To ascertain whether the prevalence of retinopathy has declined over the last 2 decades in individuals with childhood‐onset type 1 diabetes and whether this might be explained by changes in lifetime HbA1c. Materials and Methods: A multicentre, retrospective, observational study, comparing 128 subjects with diabetes onset in 2000‐2003 assessed for retinopathy in 2016‐2019, with a previous cohort of 115 individuals diagnosed in 1990‐1993 and assessed for retinopathy in 2007‐2009, was conducted. The two cohorts had both a similar diabetes duration and age at diagnosis. Retinal photographs were centrally graded. Lifetime HbA1c and its variability, estimated as the ratio between intrapersonal mean and standard deviation of HbA1c, were evaluated. Results: The prevalence of any retinopathy in the new and old cohort was 24.2% and 43.5% ( P < .003), respectively, and that of severe retinopathy was 1.7% and 9.6% ( P = .018). Lifetime HbA1c was lower in the new cohort (7.8% ± 0.8% vs. 8.1% ± 0.8%; P = .002) during all periods following the first 5 years after diagnosis. Patients without retinopathy in the two cohorts had similar levels of HbA1c. Compared with patients without retinopathy, those with retinopathy had higher lifetime HbA1c and long‐term HbA1c variability. However, on multiple regression analysis, only lifetime HbA1c was independently associated with retinopathy ( P = .0018). Conclusions: The risk of developing retinopathy was nearly halved in children who developed type 1 diabetes in the new millennium compared with previous cohorts. These results confirm that maintaining the lowest possible levels of HbA1c throughout lifetime protects from diabetic retinopathy.


  • Whole lipid profile and not only HDL cholesterol is impaired in children with coexisting type 1 diabetes and untreated celiac disease

    by Silvana Salardi, Giulio Maltoni, Stefano Zucchini, Dario Iafusco, Angela Zanfardino, Santino Confetto, Sonia Toni, Maximiliano Zioutas, Marco Marigliano, Vittoria Cauvin, et al.

    Low HDL cholesterol (HDL-C) levels have been described in patients with coexisting type 1 diabetes mellitus (T1DM) and celiac disease (CD). Data on other possible lipid abnormalities that could further increase cardiovascular risk in these patients are scarce and incomplete. Aim of this retrospective multicenter study was to evaluate whole lipid profiles, besides HDL-C, in children with T1DM associated with biopsy-proven CD, and to investigate the influence of age and degree of adherence to gluten-free diet (GFD) on lipid changes.


  • Open Access

    Celiac Disease Negatively Influences Lipid Profiles in Young Children With Type 1 Diabetes: Effect of the Gluten-Free Diet

    by Silvana Salardi, Giulio Maltoni, Stefano Zucchini, Dario Iafusco, Santino Confetto, Angela Zanfardino, Sonia Toni, Barbara Piccini, Maximiliano Zioutas, Marco Marigliano, et al.

    The association between low HDL cholesterol (HDL-C) concentrations and increased cardiovascular risk is well established. Low HDL-C levels were found in subjects with type 1 diabetes (T1D) who presented complications and in untreated subjects with celiac disease (CD). The association between TID and CD might therefore enhance this lipid abnormality and accelerate the atherosclerotic process


  • Ketoacidosis at diagnosis in childhood-onset diabetes and the risk of retinopathy 20years later

    by Silvana Salardi, Massimo Porta, Giulio Maltoni, Franco Cerutti, Silvia Rovere, Dario Iafusco, Stefano Tumini, Vittoria Cauvin, Stefano Zucchini, Francesco Cadario, et al.


  • Open Access

    Infant and Toddler Type 1 Diabetes

    by Silvana Salardi, Massimo Porta, Giulio Maltoni, Flavia Rubbi, Silvia Rovere, Franco Cerutti, Dario Iafusco, Stefano Tumini, Vittoria Cauvin, the Diabetes Study Group of the Italian Society of Paediatric Endocrinology and Diabetology (ISPED)

    OBJECTIVE: To compare the effect of the prepubertal duration of diabetes on the occurrence of complications in two groups of patients after the same number of years of the disease. RESEARCH DESIGN AND METHODS: This multicenter study enrolled 105 patients aged 16–40.3 years; 53 were prepubertal at diagnosis (aged 0–3) and 52 were pubertal (Tanner stage) and aged 9–14.9. The mean duration of disease was 19.8 and 19.5 years for prepubertal and pubertal patients, respectively. In all patients, retinal photographs were taken and centrally graded. Urinary albumin excretion (UAE; 86 case subjects), blood pressure (BP; 89 case subjects), and lifetime HbA1c (72 case subjects) were also evaluated. RESULTS: The prevalence of diabetic retinopathy (DR) was higher in pubertal than in prepubertal patients, both for any grade DR (71 vs. 40%, P = 0.002) and for mild or more severe DR (P = 0.005). The prevalence of abnormal UAE was not different in the two groups. Hypertension was found only in three patients, all pubertal at diagnosis. In the small group with moderate-to-severe DR, lifetime HbA1c levels, as percentages above the upper normal reference value, were higher (P < 0.01) in prepubertal than in pubertal patients. CONCLUSIONS: If diabetes is diagnosed in infants or toddlers and the prepubertal duration of diabetes is very long, the patients seem to be protected against DR. This protection disappears if lifetime metabolic control is bad. Instead, when onset is at puberty, the DR risk is higher and less dependent on metabolic control and may be influenced by age-related factors, such as BP.


  • Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young

    by Giulio Maltoni, Stefano Zucchini, Mirella Scipione, Vilma Mantovani, Silvana Salardi, Alessandro Cicognani

    Maltoni G, Zucchini S, Scipione M, Mantovani V, Salardi S, Cicognani A. Onset of type 1 diabetes mellitus in two patients with maturity onset diabetes of the young. The association between maturity onset diabetes of the young (MODY) and type 1 diabetes mellitus (T1DM) has been rarely described. We report two patients affected by MODY who developed T1DM. Case 1: a 4‐yr‐old girl referred for glycosuria presented hemoglobin A1c (HbA1c) of 6.6%. Islet cell antibodies (ICA) and anti‐glutamic acid decarboxylase (GADA) were initially negative. As her father, uncle and grandmother showed mild hyperglycemia, they were screened for MODY 2. A novel mutation in glucokinase gene was found in the family. Few months later, her glycemic control worsened consistently and she required insulin treatment. A high titer of GADA and ICA was then detected. Six years afterwards insulin requirement is 0.8 U/kg and HbA1c 6.7%. Case 2: a 15‐yr‐old boy treated for growth hormone deficiency was found with a blood glucose level of 106 mg/dL. HbA1c was 7.2%, ICA and GADA were negative. Family history was positive for autoimmune diseases and type 2 diabetes mellitus. The patient was investigated for MODY 2 and MODY 3, and a mutation of hepatocyte nuclear factor‐1 alpha gene was found. The same mutation was found in the mother who had never been referred for hyperglycemia. After 1 yr, due to an unjustified worsening of the metabolic control, autoimmunity was again investigated and a mild positivity was found. He then required insulin therapy and after 5 yr current HbA1c was 8.2%. The diagnosis of MODY does not exclude the risk of developing T1DM. Therefore autoimmunity should be investigated when ordinary treatments fail and metabolic control unexpectedly worsens.


  • Open Access

    High Rate of Regression From Micro-Macroalbuminuria to Normoalbuminuria in Children and Adolescents With Type 1 Diabetes Treated or Not With Enalapril

    by Silvana Salardi, Claudia Balsamo, Stefano Zucchini, Giulio Maltoni, Mirella Scipione, Alessandra Rollo, Stefano Gualandi, Alessandro Cicognani

    OBJECTIVE: To evaluate the frequency of normalization, the persistence of remission, and the impact on normalization of glycemic control and lipid profile, we analyzed data from a retrospective observational cohort study of type 1 diabetic children and adolescents with abnormal urinary albumin excretion (UAE). RESEARCH DESIGN AND METHODS: All diabetic children and adolescents (n = 41) who had persistent abnormal UAE in the period of 1984 to 2008 and followed up until 2009 (follow-up duration = 13.1 ± 6.2 years) were included in the study. Nine patients progressed to macroalbuminuria; 24 patients were administered ACE inhibitor treatment. RESULTS: The cumulative prevalence of abnormal UAE was 9%. During follow-up, 14 of 17 untreated and 19 of 24 treated patients reverted to normoalbuminuria. In the remission group compared with the nonremission group, A1C levels during follow-up decreased (7.5 ± 1.0 vs. 9.4 ± 1.2%, P < 0.0001) and serum HDL cholesterol increased (52.7 ± 11.3 vs. 42.7 ± 8.6 mg/dL, P < 0.05). The micro-macroalbuminuric patients had lower HDL cholesterol (51.0 ± 11.4 vs. 62.4 ± 13.6 mg/dL, P < 0.0001) than 134 normoalbuminuric diabetic patients. CONCLUSIONS: Microalbuminuria and macroalbuminuria were not permanent in most of our diabetic children and adolescents. If abnormal UAE values are high and persist for >1 year, only long-lasting treatment with ACE inhibitors seems able to induce persistent remission, especially when associated with good metabolic control and high HDL cholesterol levels.


    • 1 December 2010
      • Vol. 81  (1) , 35-9

    Type 1 diabetes (T1DM) in children and adolescents of immigrated families in Emilia-Romagna (Italy).

    by Patrizia Banin, Fiorenza Rimondi, Aldo De Togni, Stefano Cantoni, Giovanni Chiari, Lorenzo Iughetti, Silvana Salardi, Stefano Zucchini, Alberto Marsciani, Tosca Suprani, et al.

    The etiology and natural history of T1DM are still unknown but certainly both genetics and environmental factors contribute to the development of the disease. Migration studies are an important tool to better understand the role of the environment. The aim of this study was to investigate some variables in diabetic children of immigrant families living in Emilia-Romagna compared with Italian diabetic children living in the same region. We recruited 73 diabetic children from immigrant families and 707 Italian diabetic children. All children were cared by Pediatric Diabetes Units of Emilia-Romagna (10 centers). The investigated variables were: gender, current age, place of birth, parents' country of origin, age at diagnosis, HbA1c and insulin regimen. No significant difference with reference to gender neither among the two ethnic groups, nor in the current mean age was observed. Mean age at diagnosis in the Italian children was lower than in immigrant patients born outside Italy--group A- (7.4 vs. 9.6, p < 0.000) and higher compared to those born in Italy--group B- (7.4 vs. 5.7 p < 0.003; A vs. B p < 0.000). The immigrant patients showed higher mean HbA1c than Italian patients (8.8 vs. 8.2, p < 0.009). A younger age at diagnosis of T1DM in immigrant children, born in Italy compared with those born in the country of origin, and with Italian patients, suggests the existence of some environmental determinants acquired with a more westernised lifestyle. Immigrant children have significantly poorer metabolic control compared with western patients. (www.actabiomedica.it)


  • Prevalence of Celiac Disease in Children With Type 1 Diabetes Mellitus Increased in the Mid‐1990s: An 18‐year Longitudinal Study Based on Anti‐endomysial Antibodies

    by Silvana Salardi, Umberto Volta, Stefano Zucchini, Erica Fiorini, Giulio Maltoni, Bernardino Vaira, Alessandro Cicognani

    Between 1987 and 2004, 331 consecutive children, all newly diagnosed with type 1 diabetes mellitus in our pediatric clinic, underwent repeated serological screening for celiac disease (CD) by means of anti‐endomysial antibodies, measured prospectively between 1994 and 2004, and retrospectively, using frozen banked serum, between 1987 and 1993. There were 22 cases (6.6%) of biopsy‐proven CD among the 331 diabetic children. The prevalence of CD was significantly (P = 0.015) higher after 1994 (10.6%) than before 1994 (3.3%). The rapid change in the risk of CD among Italian diabetic children that occurred in the mid‐1990s could be related to changes in environmental factors, namely, eating habits and viral infections.


    • 1 April 2008
      • Vol. 79  (1) , 57-64

    Insulin pump therapy in children and adolescents with type 1 diabetes: the Italian viewpoint.

    by Leonardo Pinelli, Ivana Rabbone, Silvana Salardi, Sonia Toni, Andrea Scaramuzza, Riccardo Bonfanti, Valentino Cherubini, Adriana Franzese, Anna Paola Frongia, Dario Lafusco, et al.

    A panel of experts of the Italian Society of Paediatric Endocrinology and Diabetology translated into Italian the international insulin pump therapy recommendations in children and adolescents with type 1 diabetes. After an extensive review of the literature using evidence-based recommendations, several issues were taken into account, such as patient selection, advantages and disadvantages, instrument choice, insulin type, therapy planning and follow-up, emergencies, nutrition, particular occasions (like parties, holidays, sick days, travels), exercise, continuous glucose monitoring and integrated system, neonatal diabetes. The panel evaluated the cost-effectiveness of insulin pump therapy compared to multiple daily injection therapy, analysing the cost-benefit ratio. Some tweak was needed due to the Italian dietetic singularity, meal schedule, climate and lifestyle. Insulin pump therapy in neonatal diabetes is a new issue and no guidelines have been published yet for this age-group. Moreover, legal issues according to the Italian law have been added and are peculiarity of our recommendations. An "informed therapeutic agreement" between the patient and his/her family and the diabetic team has to be signed before starting insulin pump therapy. We think that nowadays the need for clinical guidelines is important and worth the effort that all countries develop faithful adaptation into their local languages taking into account specific contexts and local peculiarities, without making substantial modifications to the original text.